30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

RTI Surgical Enrolls 1st Patient in FORTE Clinical Study of Fortilink Interbody -

RTI Surgical enrolled the first patient in a clinical evaluation of the Fortilink® interbody fusion device in the treatment of degenerative disc disease. The study, named FORTE, is a prospective, postmarket evaluation of the safety and performance of the Fortilink-C, -TS, and -L Interbody Fusion systems made with TETRAfuse® 3D printed polymer material. Its primary objective is to assess radiographic evidence of fusion at three months (Fortilink-C IBF) or six months post-op (Fortilink-TS and Fortilink-L IBF). The FORTE study will collect and evaluate real world data on adult subjects, exploring pain reduction and procedural and long-term performance. The multicenter study will include 150 patients at up to 20 sites in the U.S. over the next 3.5 years, with post-procedure evaluations post-procedurally at intervals throughout 24 months for study data collection. All subjects are expected to be enrolled in 1Q20. (RTI Surgical, 3/20/19)